Introduction
Building a healthcare AI startup is no small feat. The path is strewn with regulatory hurdles, fundraising challenges, and the constant pressure to keep your team motivated while cutting through layers of red tape. Robhy Bustami, CEO of BioticsAI, recently shared his firsthand experience on the Build Mode podcast, offering a rare glimpse into how his company navigated these treacherous waters. This guide distills Bustami’s insights into a actionable, step-by-step roadmap for any founder looking to break into regulated healthcare AI.
What You Need
- Regulatory Knowledge – Familiarity with FDA guidelines, ISO standards, and HIPAA compliance.
- Financial Resources – Access to seed funding, venture capital, or grant opportunities.
- Expert Team – Engineers, clinicians, regulatory specialists, and business development professionals.
- Resilience – Patience for long approval cycles and frequent pivots.
- Clear Value Proposition – A solution that addresses a real clinical need.
Step-by-Step Guide
Step 1: Understand the Regulatory Landscape Before You Build
Before writing a single line of code, immerse yourself in the regulations that govern medical devices and AI software. Bustami emphasizes that early regulatory mapping prevents costly redesigns later. Start by identifying which FDA classification applies to your product—Class II or Class III—and study the 510(k) or De Novo pathway requirements. Engage a regulatory consultant or a law firm with healthcare expertise. Create a compliance checklist that covers data privacy (HIPAA), quality management (ISO 13485), and cybersecurity (FDA premarket guidance). This foundational step will shape your entire development process.
Step 2: Design Your AI with FDA Approval in Mind
Bustami’s team designed BioticsAI’s algorithms to be transparent and explainable, a key requirement for FDA review. Structure your machine learning pipeline to allow full traceability: document data sources, validation methods, and performance metrics. Use real-world clinical data for training, and plan for continuous validation post-deployment. Implement a change control process for algorithm updates, as the FDA expects a clear methodology for handling modifications. Consider adopting a ‘software as a medical device’ (SaMD) framework from the International Medical Device Regulators Forum (IMDRF) to align with global standards.
Step 3: Secure Funding with Realistic Expectations
Fundraising in healthcare is slower and more due diligence-intensive than in other tech sectors. Bustami advises founders to prepare for a longer sales cycle and to target investors who understand medtech timelines. Build a pitch deck that emphasizes clinical validation, market size, and regulatory strategy—not just technology hype. Explore non-dilutive funding sources like NIH SBIR/STTR grants or EU Horizon programs. Once you have a clear regulatory plan, approach VCs with a healthcare focus. Bustami notes that demonstrating an FDA interaction or a pre-submission meeting can significantly boost investor confidence.
Step 4: Cultivate a Resilient Team Culture
Long approval cycles and frequent regulatory pivots can drain team morale. Bustami stresses the importance of transparent communication and celebrating small wins. Set milestones that go beyond product launches—for example, completing a clinical study, passing an audit, or filing a 510(k). Foster a culture where failure is seen as a learning step. Use regular all-hands meetings to share progress on regulatory submissions and fundraising, so everyone feels connected to the mission. Consider cross-training team members so no single regulatory setback halts the entire project.
Step 5: Cut Through Red Tape Efficiently
Bustami recommends building relationships with FDA reviewers early through pre-submission meetings. Prepare a well-structured Q-Submission to ask specific questions about study designs or algorithm validations. Leverage digital tools for regulatory document management, like compliance software that tracks deadlines and evidence. Assign a dedicated ‘regulatory lead’ whose sole job is to monitor changes in guidelines and maintain communication with notified bodies. Bustami also suggests participating in FDA workshops and public dockets to stay ahead of policy shifts.
Step 6: Validate and Iterate with Clinical Partners
Partner with hospitals or research institutions early to run pilot studies. Bustami’s team used clinical collaborators to gather real-world performance data, which strengthened their FDA submission. Design your validation studies to answer both scientific and regulatory questions: What is the sensitivity/specificity? Are there biases in underrepresented groups? Use iterative feedback loops to refine the algorithm while maintaining compliance. Document every change and its rationale—this audit trail will be crucial during inspections.
Step 7: Plan for Post-Market Surveillance
FDA approval is not the finish line. Bustami highlights that post-market monitoring is mandatory for AI-based devices. Set up a system to collect real-world performance data, adverse events, and user feedback. Implement a risk management process compliant with ISO 14971 to update your hazard analysis as new data comes in. Prepare a complaint handling process that ties back to your regulatory reporting obligations. This ongoing vigilance not only satisfies FDA requirements but also builds trust with clinicians and patients.
Tips for Success
- Start regulatory conversations early – Even if you’re pre-revenue, file a pre-submission to get FDA feedback.
- Diversify funding sources – Don’t rely solely on VCs; mix grants, angel investors, and strategic partnerships.
- Motivate with purpose – Regularly remind the team that their work directly impacts patient lives.
- Embrace slow and steady – Healthcare rewards persistence; avoid rushing to market without proper validation.
- Network with peers – Join medtech founder groups to share regulatory strategies and avoid common pitfalls.
Building in healthcare is not for the impatient, but as Robhy Bustami’s journey shows, the rewards—both financial and in human impact—are immense. Follow these steps, stay adaptable, and keep your eyes on the ultimate goal: improving patient outcomes with responsible AI.